Position history for Pacer Advisors, Inc.'s holdings in REGENERON PHARMACEUTICALS
Pacer Advisors, Inc. holds 397,666 shares of REGN (REGENERON PHARMACEUTICALS), worth $306.9M as of 2025-Q4. The position was decreased (-10.7% shares). REGN represents 0.8% of Pacer Advisors, Inc.'s portfolio.
Current Value
$306.9M
Current Shares
397,666
Total Value Change
+$289.6M
Total Shares Change
+381,202
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 397,666 |
-10.7% |
| $306.9M |
| 0.8% |
| $773.94 |
0 |
| 2025-Q3 | Increased | 445,325 | +0.0% | $250.4M | 0.6% | $560.05 | 43 |
| 2025-Q2 | Increased | 445,134 | +9.3% | $233.7M | 0.6% | $519.56 | 47 |
| 2025-Q1 | Increased | 407,370 | +2296.9% | $258.4M | 0.6% | $634.66 | 70 |
| 2024-Q4 | Decreased | 16,996 | -13.0% | $12.1M | 0.0% | $698.71 | 0 |
| 2024-Q3 | Increased | 19,540 | +18.7% | $20.5M | 0.0% | $1,036.94 | 33 |
| 2024-Q2 | Increased | 16,464 | +9.5% | $17.3M | 0.0% | $1,045.23 | 31 |